Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

SeaSpine Holdings Corporation SPNE NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.38
-1.7%

SeaSpine Holdings Corporation (SPNE) is a Medical - Devices company in the Healthcare sector, currently trading at $9.54. It has a SharesGrow Score of 41/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Analyst consensus target is SPNE = $9 (-1.7% upside).

Financials: revenue is $191M, +10.7%/yr average growth. Net income is $54M (loss), growing at -17.7%/yr. Net profit margin is -28.4% (negative). Gross margin is 59.9% (-1.1 pp trend).

Balance sheet: total debt is $8M against $312M equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 1.57 (strong liquidity). Debt-to-assets is 2.1%. Total assets: $377M.

Analyst outlook: 9 / 10 analysts rate SPNE as buy (90%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 35/100 (Fail), Growth 48/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 54/100 (Partial), Future 74/100 (Pass), Income 10/100 (Fail).

$9.38
▼ 1.68% Downside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for SeaSpine Holdings Corporation, the average price target is $9.38, with a high forecast of $12.00, and a low forecast of $6.75.
Highest Price Target
$12.00
Average Price Target
$9.38
Lowest Price Target
$6.75

SPNE SharesGrow Score Overview

48/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 35/100
Valuation — P/E, PEG, Forward PEG
GROWTH 48/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 54/100
Gross margin is + market cap
FUTURE 74/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SPNE

✗
VALUE Fail
35/100
SPNE trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $9, implying -5.7% from the current price $10. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
48/100
SPNE: +10.7%/yr revenue is, -17.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet SPNE: Debt-to-Equity (D/E) ratio 0.03 (conservative), Current ratio is 1.57 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
54/100
SPNE: Gross margin is 59.9% (-1.1 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 54/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
74/100
Analyst outlook: 9 / 10 analysts rate SPNE as buy (90%). Analyst consensus target is $9 (-5.7% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
SPNE: Net profit margin is -28.4%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range5.48-13.6448
Volume1.16M
Avg Volume (30D)261.87K
Beta (1Y)0.00
Share Statistics
EPS (TTM)-1.62
Shares Outstanding$33.6M
IPO Date2015-06-17
Employees523
CEOKeith C. Valentine
Financial Highlights & Ratios
Revenue (TTM)$191.45M
Gross Profit$114.59M
EBITDA$-55.45M
Net Income$-54.35M
Operating Income$-60.98M
Total Cash$83.11M
Total Debt$8.1M
Net Debt$-75.01M
Total Assets$377.27M
Price / Earnings (P/E)-5.9
Analyst Forecast
1Y Price Target$9.38
Target High$12.00
Target Low$6.75
Upside-1.7%
Rating ConsensusBuy
Analysts Covering10
Buy 90% Hold 10% Sell 0%
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS81255T1088

Price Chart

Track all markets on TradingView
SPNE
SeaSpine Holdings Corporation ↗  ·  NASDAQ Global Select
Healthcare • Medical - Devices
5.48 52WK RANGE 13.64

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message